Skip to main content

Table 2 ROTEM findings on emergency room admission

From: Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients

  NCT group (n = 23) FC group (n = 21) FC-PCC group (n = 17) P-values
   FC-PCC versus NCT FC-PCC versus FC
EXTEM    
CT, sec 58.2 ± 9.5 70.2 ± 21.6 72.6 ± 31.5 0.045 ns
CFT, sec 102.3 ± 29.9 116.0 (96.5 to 160.0) 123.0 (109.0 to 165.0) 0.001 ns
CA10, mm 55.2 ± 6.7 48.1 ± 7.8 46.3 ± 9.2 0.001 ns
FIBTEM    
CA10, mm 12.0 (10.0 to 15.0) 8.0 (7.0 to 12.5) 8.0 (4.3 to 11.8) 0.0094 ns
  1. CA10, clot amplitude after 10 minutes running time; CT, clotting time; CFT, clot formation time; EXTEM, extrinsically activated test; FIBTEM, extrinsically activated test plus cytochalasin D; NCT group, no coagulation therapy; FC group, fibrinogen concentrate only; FC-PCC group, prothrombin complex concentrate and fibrinogen concentrate. Data are presented as mean ± standard deviation or median (interquartile range).
  2. P-values are derived from t-test or Mann-Whitney U-test; significance level P <0.05; ns, not significant.